These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17627956)

  • 1. Inositol hexaphosphate: a potential chelating agent for uranium.
    Cebrian D; Tapia A; Real A; Morcillo MA
    Radiat Prot Dosimetry; 2007; 127(1-4):477-9. PubMed ID: 17627956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pH on du intake and removal by CBMIDA and EHBP.
    Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
    Health Phys; 2007 Jan; 92(1):10-4. PubMed ID: 17164594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats.
    Fukuda S; Iida H; Ikeda M; Yan X; Xie Y
    Health Phys; 2005 Jul; 89(1):81-8. PubMed ID: 15951694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of bicarbonate and its combination with chelating agents used for the removal of depleted uranium in rats.
    Fukuda S; Ikeda M; Nakamura M; Katoh A; Yan X; Xie Y; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):191-8. PubMed ID: 18274996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical evaluation of 2,3-dimercaptosuccinic acid as a radiation nephrotoxicity protective agent during radiopeptide therapy of neuroendocrine malignancy.
    Moorin RE; Meyrick DP; Rose A
    Nucl Med Commun; 2007 Apr; 28(4):261-6. PubMed ID: 17325588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
    Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
    Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium trisodium DTPA in rats with puncture wound contaminated by 90Y-chloride.
    Watanabe N; Tanada S; Sasaki Y
    Radiat Prot Dosimetry; 2005; 114(4):509-13. PubMed ID: 15899907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uranium chelating ability of decorporation agents in serum evaluated by X-ray absorption spectroscopy.
    Uehara A; Matsumura D; Tsuji T; Yakumaru H; Tanaka I; Shiro A; Saitoh H; Ishihara H; Homma-Takeda S
    Anal Methods; 2022 Jun; 14(24):2439-2445. PubMed ID: 35694955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
    Grases F; Perelló J; Prieto RM; Simonet BM; Torres JJ
    Life Sci; 2004 May; 75(1):11-9. PubMed ID: 15102518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioaccumulation and behavioural effects of depleted uranium in rats exposed to repeated inhalations.
    Monleau M; Bussy C; Lestaevel P; Houpert P; Paquet F; Chazel V
    Neurosci Lett; 2005 Dec; 390(1):31-6. PubMed ID: 16115730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new formulation containing calixarene molecules as an emergency treatment of uranium skin contamination.
    Spagnul A; Bouvier-Capely C; Phan G; Rebière F; Fattal E
    Health Phys; 2010 Sep; 99(3):430-4. PubMed ID: 20699708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute toxicity of subcutaneously administered depleted uranium and the effects of CBMIDA in the simulated wounds of rats.
    Fukuda S; Ikeda M; Nakamura M; Yan X; Xie Y
    Health Phys; 2009 Apr; 96(4):483-92. PubMed ID: 19276709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of colonic cancer by dietary phytic acid.
    Graf E; Eaton JW
    Nutr Cancer; 1993; 19(1):11-9. PubMed ID: 8383315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
    Ramounet-Le Gall B; Grillon G; Rateau G; Burgada R; Bailly T; Fritsch P
    Radiat Prot Dosimetry; 2003; 105(1-4):535-8. PubMed ID: 14527023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats.
    Henge-Napoli MH; Ansoborlo E; Chazel V; Houpert P; Paquet F; Gourmelon P
    Int J Radiat Biol; 1999 Nov; 75(11):1473-7. PubMed ID: 10597920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.